TY - JOUR
T1 - Introduction and methods of the evidence-based guidelines for the diagnosis and management of autism spectrum disorder by the Italian National Institute of Health
AU - Morgano, Gian Paolo
AU - Fulceri, Francesca
AU - Nardocci, Franco
AU - Barbui, Corrado
AU - Ostuzzi, Giovanni
AU - Papola, Davide
AU - Fatta, Laura Maria
AU - Fauci, Alice Josephine
AU - Coclite, Daniela
AU - Napoletano, Antonello
AU - De Crescenzo, Franco
AU - D'Alò, Gian Loreto
AU - Amato, Laura
AU - Cinquini, Michela
AU - Iannone, Primiano
AU - Schünemann, Holger Jens
AU - Scattoni, Maria Luisa
AU - Arduino, Maurizio
AU - Bellosio, Cristina
AU - Biasci, Sandra
AU - Buono, Serafino
AU - Cappa, Corrado
AU - Cordò, Concetta
AU - Di Tommaso, Emanuela
AU - Duff, Clelia Maria
AU - Felici, Claudia
AU - Massagli, Angelo
AU - Molteni, Massimo
AU - Reali, Laura
AU - Tancredi, Raffaella
AU - Valeri, Giovanni
AU - Venturini, Lorella
AU - Zuddas, Alessandro
AU - Andreoli, Mauro
AU - Bergamin, Consuelo
AU - Bertelli, Marco
AU - Catania, Danilo
AU - Cavagnola, Roberto
AU - Cirrincione, Pietro
AU - Corti, Serafino
AU - Crognale, Marusca
AU - Faggioli, Raffaella
AU - Giogoli, Anna Maria
AU - Grittani, Serenella
AU - Keller, Roberto
AU - Pace, Pasqualina
AU - Politi, Pierluigi
AU - Starace, Fabrizio
AU - Valenti, Marco
AU - Balduzzi, Sara
AU - on behalf of the Italian National Institute of Health guidelines working group on Autism Spectrum Disorder
PY - 2020/3/26
Y1 - 2020/3/26
N2 - Background: Autism Spectrum Disorder (ASD) is a neuro-developmental disorder that affects communication and behavior with a prevalence of approximately 1% worldwide. Health outcomes of interventions for ASD are largely Participant Reported Outcomes (PROs). Specific guidelines can help support the best care for people with ASD to optimize these health outcomes but they have to adhere to standards for their development to be trustworthy. Objective: The goal of this article is to describe the new methodological standards of the Italian National Institute of Health and novel aspects of this guideline development process. This article will serve as a reference standard for future guideline development in the Italian setting. Methods: We applied the new standards of the Italian National Institute of Health to the two guidelines on diagnosis and management of children/adolescents and adults with ASD, with a focus on the scoping, panel composition, management of conflict of interest, generation and prioritization of research questions, early stakeholders' involvement, and PROs. Recommendations are based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence-to-Decision frameworks. Results: Following a public application process, the ISS established two multidisciplinary panels including people with ASD and/or their caregivers. Seventy-nine research questions were identified as potentially relevant for the guideline on children and adolescents with ASD and 31 for the one on adults with ASD. Questions deemed to have the highest priority were selected for inclusion in the guidelines. Other stakeholders valued their early involvement in the process which will largely focus on PROs. The panels then successfully piloted the development of recommendations using the methodological standards and process set by the ISS with a focus on PROs. Conclusions: In this article, we describe the development of practice guidelines that focus on PROs for the diagnosis and management of ASD based on novel methods for question prioritization and stakeholder involvement. The recommendations allow for the adoption or adaptation to international settings.
AB - Background: Autism Spectrum Disorder (ASD) is a neuro-developmental disorder that affects communication and behavior with a prevalence of approximately 1% worldwide. Health outcomes of interventions for ASD are largely Participant Reported Outcomes (PROs). Specific guidelines can help support the best care for people with ASD to optimize these health outcomes but they have to adhere to standards for their development to be trustworthy. Objective: The goal of this article is to describe the new methodological standards of the Italian National Institute of Health and novel aspects of this guideline development process. This article will serve as a reference standard for future guideline development in the Italian setting. Methods: We applied the new standards of the Italian National Institute of Health to the two guidelines on diagnosis and management of children/adolescents and adults with ASD, with a focus on the scoping, panel composition, management of conflict of interest, generation and prioritization of research questions, early stakeholders' involvement, and PROs. Recommendations are based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence-to-Decision frameworks. Results: Following a public application process, the ISS established two multidisciplinary panels including people with ASD and/or their caregivers. Seventy-nine research questions were identified as potentially relevant for the guideline on children and adolescents with ASD and 31 for the one on adults with ASD. Questions deemed to have the highest priority were selected for inclusion in the guidelines. Other stakeholders valued their early involvement in the process which will largely focus on PROs. The panels then successfully piloted the development of recommendations using the methodological standards and process set by the ISS with a focus on PROs. Conclusions: In this article, we describe the development of practice guidelines that focus on PROs for the diagnosis and management of ASD based on novel methods for question prioritization and stakeholder involvement. The recommendations allow for the adoption or adaptation to international settings.
KW - Autism Spectrum disorder
KW - Diagnosis
KW - GRADE approach
KW - Guideline
KW - Healthcare decision
KW - Italian national guidelines system
KW - Italian National Institute of health
KW - Recommendations
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85082561368&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082561368&partnerID=8YFLogxK
U2 - 10.1186/s12955-020-01320-4
DO - 10.1186/s12955-020-01320-4
M3 - Article
C2 - 32216833
AN - SCOPUS:85082561368
SN - 1477-7525
VL - 18
JO - Health and Quality of Life Outcomes
JF - Health and Quality of Life Outcomes
IS - 1
M1 - 81
ER -